Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Thompson

Showing results (111-120 of 484) with videos related to

Pageof 49
Sort By:
The Journal of Urology|February 1, 2015
The Next Generation of Clinical Decision Making Tools: Development of a Real-Time Prediction Tool for Outcome of Prostate Biopsy in Response to a Continuously Evolving Prostate Cancer LandscapeAndreas N Strobl, Ian M Thompson, Andrew J Vickers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
Biased hormonal therapy duration analysis makes results uninterpretableCatherine M Tangen, Bryan H Goldman, Gregory P Swanson, et al.
Journal of the National Cancer Institute|April 2, 2014
ResponseTheodore M Brasky, Ian M Thompson, Irena B King, et al.
Expert Opinion on Pharmacotherapy|April 26, 2006
Chemoprevention of prostate cancer with finasterideEdith D Canby-Hagino, Timothy C Brand, Javier Hernandez, et al.
European Urology Focus|July 21, 2017
Smoking and Prostate Cancer: A Systematic ReviewCosimo De Nunzio, Gerald L Andriole, Ian M Thompson, et al.
The Journal of Urology|January 10, 2004
Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trialsCatherine M Tangen, Phyllis J Goodman, John J Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Phase III prostate cancer prevention trials: are the costs justified?Ian M Thompson, Catherine M Tangen, Eric A Klein, et al.
Urology|December 12, 2002
Questionnaire-based outcomes of urinary incontinence and satisfaction rates after radical prostatectomy in a national study populationMichael Sebesta, R Duane Cespedes, Eva Luhman, et al.
Mini Reviews in Medicinal Chemistry|April 8, 2010
Natural products: potential for developing Phellodendron amurense bark extract for prostate cancer managementAddanki P Kumar, Heather Graham, Craig Robson, et al.
The Urologic Clinics of North America|May 9, 2003
Chemoprevention of prostate cancer. Focus on key opportunities and clinical trialsRobin Leach, Brad Pollock, Joseph Basler, et al.
Pageof 49

Showing results (111-120 of 484) with videos related to

Sort By:
Pageof 49
The Journal of Urology|February 1, 2015
The Next Generation of Clinical Decision Making Tools: Development of a Real-Time Prediction Tool for Outcome of Prostate Biopsy in Response to a Continuously Evolving Prostate Cancer LandscapeAndreas N Strobl, Ian M Thompson, Andrew J Vickers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
Biased hormonal therapy duration analysis makes results uninterpretableCatherine M Tangen, Bryan H Goldman, Gregory P Swanson, et al.
Journal of the National Cancer Institute|April 2, 2014
ResponseTheodore M Brasky, Ian M Thompson, Irena B King, et al.
Expert Opinion on Pharmacotherapy|April 26, 2006
Chemoprevention of prostate cancer with finasterideEdith D Canby-Hagino, Timothy C Brand, Javier Hernandez, et al.
European Urology Focus|July 21, 2017
Smoking and Prostate Cancer: A Systematic ReviewCosimo De Nunzio, Gerald L Andriole, Ian M Thompson, et al.
The Journal of Urology|January 10, 2004
Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trialsCatherine M Tangen, Phyllis J Goodman, John J Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Phase III prostate cancer prevention trials: are the costs justified?Ian M Thompson, Catherine M Tangen, Eric A Klein, et al.
Urology|December 12, 2002
Questionnaire-based outcomes of urinary incontinence and satisfaction rates after radical prostatectomy in a national study populationMichael Sebesta, R Duane Cespedes, Eva Luhman, et al.
Mini Reviews in Medicinal Chemistry|April 8, 2010
Natural products: potential for developing Phellodendron amurense bark extract for prostate cancer managementAddanki P Kumar, Heather Graham, Craig Robson, et al.
The Urologic Clinics of North America|May 9, 2003
Chemoprevention of prostate cancer. Focus on key opportunities and clinical trialsRobin Leach, Brad Pollock, Joseph Basler, et al.
Pageof 49